| Literature DB >> 31296949 |
Philani Vusumuzi Hlophe1, Lwazi Charles Mahlalela1, Langelihle Nsikayezwe Dlamini2.
Abstract
The development of heterojunctions is the current focus of the scienEntities:
Year: 2019 PMID: 31296949 PMCID: PMC6624298 DOI: 10.1038/s41598-019-46498-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1SEM images of (a) MIL-125(Ti), (b) BiVO4, (c) 1–1 Bi:Ti, (d) 2–3 Bi:Ti and (e) 3-2 Bi:Ti. The inserts in (a) and (b) are redrawn morphologies of the pristine MIL-125(Ti) and platelet-like BiVO4 respectively.
Figure 2TEM images (a) MIL-125(Ti) (b) BiVO4. (c) SAED patterns of BiVO4.
Figure 3TEM images and respective SAED patterns of (a) 1–1 Bi:Ti, (b) 2–3 Bi:Ti and (c) 3-2 Bi:Ti composites of MIL-125(Ti)/BiVO4.
Figure 4(A) XRD patterns of (a) BiVO4, (b) 1–1 Bi:Ti, (c) 3–2 Bi:Ti, (d) 2–3 Bi:Ti and (e) MIL-125(Ti). (B,C) are zoomed in images showing MIL-125(Ti) patterns in the composites.
Figure 5Raman spectra of (a) MIL-125(Ti), (b) 1–1 Bi:Ti (c) 2–3 Bi:Ti, (d) 3-2 Bi:Ti and (e) BiVO4.
Figure 6Tauc plots of the synthesized nanoparticles.
Figure 7Band positions of the heterojunctions (a) 1–1 Bi:Ti, (b) 2–3 Bi:Ti and (c) 3-2 Bi:Ti.
Figure 8The XPS spectra of 3-2 Bi:Ti; (a) full survey spectrum, (b) Bi 4 f spectrum, (c) V 2p spectrum, (d) Ti 2p spectrum, (e) O 1 s spectra and (f) C 1 s spectra.
Figure 9The VBs spectra of (a) BiVO4 and (b) 3-2 Bi:Ti.
Figure 10(A) PL measurements of (a) platelet-like BiVO4, (b) 3-2 Bi:Ti (PM), (c) 1–1 Bi:Ti, (d) 2–3 Bi:Ti and (e) 3-2 Bi:Ti. (B) PL measurement of MIL-125(Ti).
Figure 11Mott-Schottky plots of (a) platelet-like BiVO4, (b) MIL-125(Ti), (c) 3-2 Bi:Ti (PM), (d) 1–1 Bi:Ti, (e) 2–3 Bi:Ti and (f) 3-2 Bi:Ti.
Figure 12Nyquist plots of (a) platelet-like BiVO4, (b) 3-2 Bi:Ti (PM), (c) MIL-125(Ti), (d) 1–1 Bi:Ti, (e) 2–3 Bi:Ti and (f) 3-2 Bi:Ti.